glp 1 b12 injections ๐ฅ How Supports GLP-1 Weight Loss Treatment When patients begin GLP-1 medications (like semaglutide or tirzepatide), the appetite decreases โ meaning: โ๏ธ You're often eating less โ๏ธ Your calorie intake drops GLP1 has been associated with a reduction in the risk of cardiovascular events in people with obesity GLP-1/GIP + B12 (Tirzepatide) |
Description
Clinically, it is mainly used to treat T2DM and causes weight reduction when used in large doses (3mg/day) (83)

Its a tiny needle, and most people are surprised by how little they feel it

Cardiovasc Res 117(11):e138e140
doi 10.1371/journal.pone.0198046 91 MarottiVXuYBohns MichalowskiCZhangWDominguesIAmeraouiHet al
:max_bytes(150000):strip_icc()/Health-GettyImages-2236560849-a1934f1e4c004a19835cb508d021388b.jpg)
youre also tuning into a more balanced, satisfying approach to eating

The second meta-analysis in 77,485 people from 28 randomized clinical trials showed that in people with type 2 diabetes, overweight, and obesity, treatment with GLP-1 receptor agonists was associated with a significant reduction of 14% in the relative risk, while separate medications, semaglutide, liraglutide, and dulaglutide, were associated with a reduction in the relative risk of 18%, 14%, and 18% for overall respiratory disease
